Central
post-stroke pain (CPSP) is a neuropathic pain syndrome
that frequently occurs following cerebral stroke. The pathogenesis
of CPSP is mainly due to thalamic injury caused by ischemia and hemorrhage.
However, its underlying mechanism is far from clear. In the present
study, a thalamic hemorrhage (TH) model was established in young male
mice by microinjection of 0.075 U of type IV collagenase into the
unilateral ventral posterior lateral nucleus and ventral posterior
medial nucleus of the thalamus. We found that TH led to microglial
pannexin (Panx)-1, a large-pore ion channel, opening within the thalamus
accompanied with thalamic tissue injury, pain sensitivities, and neurological
deficit, which were significantly prevented by either intraperitoneal
injection of the Panx1 blocker carbenoxolone or intracerebroventricular
perfusion of the inhibitory mimetic peptide 10Panx. However, inhibition
of Panx1 has no additive effect on pain sensitivities upon pharmacological
depletion of microglia. Mechanistically, we found that carbenoxolone
alleviated TH-induced proinflammatory factors transcription, neuronal
apoptosis, and neurite disassembly within the thalamus. In summary,
we conclude that blocking of microglial Panx1 channels alleviates
CPSP and neurological deficit through, at least in part, reducing
neural damage mediated by the inflammatory response of thalamic microglia
after TH. Targeting Panx1 might be a potential strategy in the treatment
of CPSP.